“…However, it is noteworthy that with more protracted and complex testing, more benefits are being associated with modafinil use rather than less, which suggests that modafinil may well deserve the title of the first well-validated pharmaceutical 'nootropic' agent. This observation is also true of non-invasive brain stimulation techniques, in which more integrative cognitive assessments and physiological recordings are yielding increasingly valuable insights into the mechanisms by which they may engender cognitive enhancement (see, for example, Battleday et al, 2014;Santarnecchi et al, 2015). In this vein, we hope our recommendations for future study will assist in advancing and consolidating the cognitive investigation of neuroenhancement agents, and, in doing so, contribute valuable information to wider discourse on the achievability and role of neuroenhancement within wider society.…”